Compound Summary
Compound Information
pindolol
Compound Name: | pindolol |
Compound CID: | 4828 |
Synonyms: | pindolol 13523-86-9 Visken Prinodolol Betapindol More... |
Iupac Name: | 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol |
InChI: | InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3 |
InChIKey: | JZQKKSLKJUAGIC-UHFFFAOYSA-N |
Canonical Smiles: | CC(C)NCC(COC1=CC=CC2=C1C=CN2)O |
Isomeric Smiles: | CC(C)NCC(COC1=CC=CC2=C1C=CN2)O |
Molecular Weight: | 248.32 |
Molecular Formula: | C14H20N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
pindolol
Molecular Weight: | 248.32 |
Molecular Formula: | C14H20N2O2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 18 |
Complexity: | 248 |
Synonyms
pindolol
| pindolol | pindolol |
|---|---|
pindolol |
13523-86-9 |
Visken |
Prinodolol |
Betapindol |
Carvisken |
Durapindol |
Pinbetol |
Calvisken |
Decreten |
Pectobloc |
Pynastin |
Blocklin L |
LB-46 |
Pindololum |
Glauco-visken |
Blockin L |
LB 46 |
Blocklin-L |
4-(2-Hydroxy-3-isopropylaminopropoxy)-indole |
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol |
1-(1H-Indol-4-yloxy)-3-(1-methylethyl)amino-2-propanol |
l-Pindolol |
1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol |
1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol |
4-(3-(Isopropylamino)-2-hydroxypropoxy)indole |
1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol |
2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino- |
2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)- |
CHEBI:8214 |
1-(1H-indol-4-yloxy)-3-(1-methylethyl)aminopropan-2-ol |
2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)- |
Glauco-Viskin |
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol |
NCGC00015786-11 |
(+-)-Pindolol |
DSSTox_CID_3476 |
DL-Pindolol |
Pindololum INN-Latin |
(-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol |
DSSTox_RID_77043 |
DSSTox_GSID_23476 |
Blocklin |
Carvisken (TN) |
SMR000059120 |
Blocklin-L (TN) |
Visken (TN) |
CCRIS 9215 |
HSDB 6539 |
1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol |
SR-01000000027 |
EINECS 236-867-9 |
EINECS 244-623-8 |
BRN 1536506 |
1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol |
DL-LB 46 |
Prestwick_397 |
CAS-13523-86-9 |
Pindolol USAN:USP:INN:BAN:JAN |
Spectrum_001109 |
(1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol |
(.+/-.)-Pindolol |
Prestwick0_000090 |
Prestwick1_000090 |
Prestwick2_000090 |
Prestwick3_000090 |
Spectrum2_001285 |
Spectrum3_000547 |
Spectrum4_000479 |
Spectrum5_001266 |
(R,S)-PINDOLOL |
CHEMBL500 |
GTPL91 |
PINDOLOL,(-) |
P 0778 |
P-6820 |
SCHEMBL5219 |
Lopac0_000955 |
Oprea1_770884 |
BSPBio_000020 |
BSPBio_002193 |
KBioGR_000958 |
KBioSS_001589 |
5-21-03-00017 (Beilstein Handbook Reference) |
DL-4-2-Hydroxy-3-(isopropylamino)propoxyindole |
MLS000069496 |
MLS002548891 |
DivK1c_000837 |
SPECTRUM1500488 |
Pindolol (JP17/USP/INN) |
SPBio_001289 |
SPBio_001959 |
BPBio1_000022 |
1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol |
DTXSID8023476 |
HMS502J19 |
KBio1_000837 |
KBio2_001589 |
KBio2_004157 |
KBio2_006725 |
KBio3_001693 |
NINDS_000837 |
1-(1H-indol-4-yloxy)-3-(propan-2-yl)aminopropan-2-ol |
2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino- |
2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)- |
HMS1568A22 |
HMS1920H16 |
HMS2089I21 |
HMS2091P20 |
HMS2095A22 |
HMS3259I07 |
HMS3262P12 |
HMS3267K17 |
HMS3369E14 |
HMS3414J03 |
HMS3678H21 |
HMS3712A22 |
HMS3742C07 |
HMS3885N04 |
Pharmakon1600-01500488 |
HY-B0982 |
Pindolol, >=98% (TLC), powder |
Tox21_110221 |
Tox21_500955 |
BDBM50019443 |
CCG-39223 |
MFCD00010530 |
NSC757276 |
PDSP1_000771 |
PDSP1_000772 |
PDSP2_000759 |
PDSP2_000760 |
(+/-)-Pindolol-d7(iso-propyl-d7) |
AKOS015969756 |
Tox21_110221_1 |
CS-4473 |
DB00960 |
LP00955 |
MCULE-7764948919 |
NC00467 |
NSC 757276 |
NSC-757276 |
SB17015 |
SDCCGSBI-0050929.P005 |
IDI1_000837 |
NCGC00015786-06 |
NCGC00015786-07 |
NCGC00015786-08 |
NCGC00015786-09 |
NCGC00015786-10 |
NCGC00015786-13 |
NCGC00015786-14 |
NCGC00015786-16 |
NCGC00015786-20 |
NCGC00015786-22 |
NCGC00024925-03 |
NCGC00024925-04 |
NCGC00024925-05 |
NCGC00024925-06 |
NCGC00024925-07 |
NCGC00261640-01 |
BS-42390 |
SBI-0050929.P004 |
AB00052072 |
EU-0100955 |
FT-0673907 |
ST50319990 |
SW196641-3 |
Z3376 |
C07445 |
C90604 |
D00513 |
AB00052072-11 |
AB00052072_12 |
AB00052072_13 |
1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol |
523P869 |
L000006 |
Q418101 |
3-indol-4-yloxy-1-(methylethyl)aminopropan-2-ol |
SR-01000000027-2 |
SR-01000000027-4 |
SR-01000000027-5 |
SR-01000000027-7 |
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol |
BRD-A97701745-001-05-3 |
BRD-A97701745-001-09-5 |
1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol # |
Pindolol, European Pharmacopoeia (EP) Reference Standard |
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol) |
Pindolol, United States Pharmacopeia (USP) Reference Standard |
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol) |
Experimental Data
pindolol
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -11 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
pindolol
Statistics Data
pindolol
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -11 | 1 | 1 |
Statistics Data Visualization
pindolol
